Ads
related to: pharmaceuticals
Search results
Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating
Investor's Business Daily· 11 hours agoOver 100 years of market history reveals that the stocks that go on to make the biggest gains tend...
UPDATE 1-Merck KGaA's Q1 adjusted profit declines less than feared
Reuters via Yahoo Finance· 6 minutes agoThe German diversified group reported 8.4% lower first-quarter earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for one-offs, at 1.45 billion euros ($1.57 billion ...
Earnings call: Fennec Pharmaceuticals Q1 2024 results and updates By Investing.com
Investing.com· 11 hours agoFennec Pharmaceuticals (NASDAQ: NASDAQ:FENC) reported a robust first quarter in 2024, with total net...
Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target Raised to $60.00 at Barclays
ETF DAILY NEWS· 1 day agoTarsus Pharmaceuticals (NASDAQ:TARS – Free Report) had its price objective raised by Barclays from $50.00 to $60.00 in a research report sent to investors on Friday morning ...
Breaking Barriers in Bioprocessing: An Interview with Himanshu Gadgil, CEO of Enzene Biosciences
BioPharma-Reporter· 19 hours agoWith a rich background in biochemistry and extensive experience in the pharmaceutical industry,...
Tonix Pharmaceuticals (NASDAQ:TNXP) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 22 hours agoStockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note issued to investors on Monday morning. The firm issued a sell ...
How Is The Market Feeling About West Pharmaceutical Servs? - West Pharmaceutical Servs (NYSE:WST)
Benzinga· 10 hours agoWest Pharmaceutical Servs's WST short percent of float has fallen 13.37% since its last report. Based on its trading volume, it would take traders 3.04 days to cover their ...
Ionis Pharmaceuticals Inc (IONS) gets rating Upgrade from Wolfe Research – Knox Daily
Knox Daily· 4 hours agoIonis Pharmaceuticals Inc’s recent filing unveils that its Director KLEIN JOSEPH III unloaded Company’s shares for reported $0.26 million on May 03 ’24. In the deal valued ...
David Abrams Exits Teva Pharmaceutical in Q1 2024, Reflecting St
Guru Focus· 8 hours agoInsights into Abrams Capital Management's Latest 13F Filings David Abrams (Trades, Portfolio), the founder and CEO of Abrams Capital Management, has a notable
...Cannabis Post-Rescheduling? Data Analytics Expert Weighs In - Corbus Pharmaceuticals...
Benzinga· 12 hours agoKey states driving this surge include New York, New Jersey and potentially Florida and Ohio, Bingham...